GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Lipum AB (OSTO:LIPUM) » Definitions » EV-to-FCF

Lipum AB (OSTO:LIPUM) EV-to-FCF : -9.29 (As of May. 23, 2024)


View and export this data going back to 2021. Start your Free Trial

What is Lipum AB EV-to-FCF?

EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, Lipum AB's Enterprise Value is kr124.11 Mil. Lipum AB's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2023 was kr-13.37 Mil. Therefore, Lipum AB's EV-to-FCF for today is -9.29.

The historical rank and industry rank for Lipum AB's EV-to-FCF or its related term are showing as below:

OSTO:LIPUM' s EV-to-FCF Range Over the Past 10 Years
Min: -10.24   Med: 0   Max: 0
Current: -9.68

OSTO:LIPUM's EV-to-FCF is ranked worse than
100% of 370 companies
in the Biotechnology industry
Industry Median: 9.66 vs OSTO:LIPUM: -9.68

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

As of today (2024-05-23), Lipum AB's stock price is kr6.25. Lipum AB's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 was kr-2.003. Therefore, Lipum AB's PE Ratio for today is At Loss.


Lipum AB EV-to-FCF Historical Data

The historical data trend for Lipum AB's EV-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Lipum AB EV-to-FCF Chart

Lipum AB Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23
EV-to-FCF
- - -1.40 -1.44 -1.44

Lipum AB Quarterly Data
Dec19 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Sep23 Dec23
EV-to-FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -1.32 -1.44 -1.75 -3.36 -1.44

Competitive Comparison of Lipum AB's EV-to-FCF

For the Biotechnology subindustry, Lipum AB's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Lipum AB's EV-to-FCF Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Lipum AB's EV-to-FCF distribution charts can be found below:

* The bar in red indicates where Lipum AB's EV-to-FCF falls into.



Lipum AB EV-to-FCF Calculation

Lipum AB's EV-to-FCF for today is calculated as:

EV-to-FCF=Enterprise Value (Today)/Free Cash Flow (TTM)
=124.113/-13.366
=-9.29

Lipum AB's current Enterprise Value is kr124.11 Mil.
Lipum AB's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was kr-13.37 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Lipum AB  (OSTO:LIPUM) EV-to-FCF Explanation

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

Lipum AB's PE Ratio for today is calculated as:

PE Ratio=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=6.25/-2.003
=At Loss

Lipum AB's share price for today is kr6.25.
Lipum AB's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was kr-2.003.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.


Lipum AB EV-to-FCF Related Terms

Thank you for viewing the detailed overview of Lipum AB's EV-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


Lipum AB (OSTO:LIPUM) Business Description

Traded in Other Exchanges
N/A
Address
Tvistevagen 48 C, Umea, SWE, 907 36
Lipum AB is a clinical-stage biopharmaceutical company specializing in the discovery and development of a novel treatment for chronic inflammatory diseases. The candidate SOL-116 is a humanized antibody designed to provide efficacious therapy by blocking a previously overlooked target molecule (BSSL) of the immune system. The development is supported by solid pre-clinical data for rheumatoid arthritis. Lipum also explores other inflammatory diseases with a high unmet medical need.

Lipum AB (OSTO:LIPUM) Headlines

No Headlines